In addition to the altered circulating uric acid metabolism, the multifactorial effects of factors such as hyperglycemia, obesity, liver dysfunction, dyslipidemia, and endothelial dysfunction possibly abolished the sex difference in the plasma XOR activity in the patients in the current study. This evidence concerns the gene XDH and obesity due to melanocortin 4 receptor deficiency.